Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
698 |
|
| Actual shortage: | 153 (22%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 544 (78%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
153 (21%) |
|
Overdue reports |
73 (48%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ROPINIROLE | 1.0MG | TABLET | Resolved | 2018-10-15 | 2019-07-08 | 64282 |
| JAMP-ROPINIROLE | 1.0MG | TABLET | Actual shortage | 2020-03-30 | 2021-04-07 | 109760 |
| JAMP-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-07-19 | 2022-07-27 | 164995 |
| JAMP-INDAPAMIDE | 1.25MG | TABLET | Actual shortage | 2017-03-20 | 2020-02-18 | 3580 |
| JAMP-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-03-30 | 2018-11-27 | 4771 |
| JAMP DICLOFENAC TOPICAL SOLUTION | 1.5% | SOLUTION | Resolved | 2023-04-11 | 2023-08-26 | 189256 |
| JAMP DICLOFENAC TOPICAL SOLUTION | 1.5% | SOLUTION | Resolved | 2025-01-04 | 2025-08-04 | 246728 |
| JAMP RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2025-03-04 | 2025-08-04 | 251932 |
| JAMP RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2025-03-04 | 2025-08-04 | 251935 |
| JAMP-ROSUVASTATIN | 10.0MG | TABLET | Resolved | 2017-12-22 | 2018-02-20 | 34221 |
| JAMP-ROSUVASTATIN | 10.0MG | TABLET | Resolved | 2017-12-22 | 2018-02-20 | 34235 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2019-10-11 | 2021-04-05 | 96198 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2019-10-11 | 2021-04-05 | 96202 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2023-04-12 | 2025-07-15 | 189373 |
| JAMP-NYSTATIN ORAL SUSPENSION USP | 100000UNIT | SUSPENSION | Resolved | 2023-11-28 | 2025-08-18 | 211795 |
| JAMP-VITAMIN D | 10000UNIT | CAPSULE | Resolved | 2022-02-14 | 2022-05-17 | 154931 |
| JAMP-VITAMIN D | 10000UNIT | TABLET | Resolved | 2022-06-13 | 2022-08-22 | 162489 |
| JAMP-VITAMIN D | 10000UNIT | TABLET | Resolved | 2024-01-08 | 2025-01-22 | 215310 |
| JAMP-VITAMIN D | 10000UNIT | TABLET | Resolved | 2024-01-08 | 2025-01-22 | 215313 |
| JAMP-VITAMIN D | 10000UNIT | TABLET | Resolved | 2024-01-08 | 2025-01-22 | 215316 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14